The Practical Evidence of Antidiabetic Combination Therapy in Korea
Status:
Completed
Trial end date:
2019-01-28
Target enrollment:
Participant gender:
Summary
This study evaluate the efficacy and safety of alogliptin and pioglitazone combination
therapy in comparison with either alogliptin or pioglitazone on glucose control in the
metformin-treated type 2 diabetic patients in Korea.